A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
0
Participant gender:
All
Summary
This is a randomized open-label, three-arm, phase 1 clinical study. The investigators aim to
investigate a Chinese Proprietary Medicine, MZRW on its tolerability, system exposure and
pharmacokinetics profile.